Physician-Supervised  ·  Telehealth In All 50 States  ·  HIPAA Compliant

Women's Health

Understanding Hormonal Hair Loss in Women: Causes and Treatments

Discover the causes of hormonal hair loss in women and explore effective treatments with MEDVera's tailored solutions.

MEDVera Medical Team7 min read

Key Highlights

  • Differentiate between androgenetic alopecia, telogen effluvium, thyroid-related loss, and postpartum shedding.
  • Understand the hormonal influences: estrogen, progesterone, testosterone, and DHEA-S.
  • Explore treatment options such as MEDVera's Women's Scalp Solution, Spironolactone, and Willow Oral.
  • MEDVera serves patients across the U.S., offering personalized telehealth solutions.

Overview

Hormonal hair loss in women is a prevalent concern, impacting self-esteem and quality of life. This guide aims to clarify the different types of hair loss, including androgenetic alopecia, telogen effluvium, thyroid-related loss, and postpartum shedding, while highlighting the hormonal influences of estrogen, progesterone, testosterone, and DHEA-S.

Mechanism of Action

Hormonal changes can significantly alter the hair growth cycle. Androgenetic alopecia, commonly referred to as female pattern baldness, involves a progressive thinning of hair due to increased sensitivity to androgens like testosterone. Conversely, telogen effluvium is often triggered by stress or hormonal fluctuations, leading to diffuse hair shedding. Thyroid imbalances can also cause thinning, while postpartum shedding is linked to the sudden drop in estrogen post-childbirth.

Clinical Evidence

Studies such as the Women's Health Study highlight the prevalence of female pattern hair loss, with reports indicating that nearly 40% of women experience noticeable hair thinning by age 50. Clinical trials like those conducted by the American Academy of Dermatology emphasize the role of anti-androgens and topical treatments in managing hair loss.

Patient Selection

Identifying the type of hair loss is crucial for effective treatment. Women experiencing gradual thinning along the part line may have androgenetic alopecia, whereas sudden, widespread shedding often suggests telogen effluvium. Thyroid function tests can help diagnose thyroid-related hair loss, while a recent childbirth history may indicate postpartum shedding.

MEDVera Protocol

MEDVera offers several treatment options tailored to women's unique needs:

  • Women's Scalp Solution: A topical blend of azelaic acid, estradiol, progesterone, and liothyronine to support scalp health and hair growth.
  • Spironolactone: An oral anti-androgen effective in reducing hair thinning caused by excess androgens.
  • Willow Oral: Combines minoxidil, spironolactone, and biotin to promote hair regrowth and strength.

FAQ

What is the difference between androgenetic alopecia and telogen effluvium? Androgenetic alopecia is a genetic condition leading to gradual hair thinning, while telogen effluvium is a temporary shedding often linked to stress or hormonal changes.

How do hormones affect hair loss? Hormones like testosterone, when elevated, can shrink hair follicles, while estrogen and progesterone help maintain the hair growth cycle.

Can thyroid problems lead to hair loss? Yes, both hyperthyroidism and hypothyroidism can disrupt the hair growth cycle, leading to thinning.

How does MEDVera personalize treatment? MEDVera offers telehealth consultations to tailor treatments like the Women's Scalp Solution and Spironolactone to individual needs.

What areas does MEDVera serve? MEDVera provides services across the U.S., including states like Texas, Florida, California, and New York.

Ready to explore? Start your free MEDVera evaluation.

MEDVera Service Areas

MEDVera provides telehealth services across the United States. Our treatments are available in:

TexasFloridaCaliforniaNew YorkGeorgiaNorth CarolinaPennsylvaniaOhioArizonaIllinoisTennesseeMichiganColoradoVirginiaWashingtonDallasHoustonMiamiLos AngelesAtlantaNew York CityPhoenixChicagoCharlottePhiladelphiaNashvilleDenverSeattleTampaAustin